1152195

Sarah E. Zauber, M.D. — FEI 3017587952

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 16, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance